← Back to Search

Behavioral Intervention

Ultrabrief Behavioral Activation for Alcohol Use Disorder (UBA Trial)

N/A
Waitlist Available
Led By Stacy Daughters, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through completion of the study, an average of 1 year
Awards & highlights

UBA Trial Summary

This trial is testing a new, single-session treatment for people with mild to moderate alcohol use disorder to see if it is feasible, acceptable, and effective.

Eligible Conditions
  • Alcohol Use Disorder

UBA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through completion of the study, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through completion of the study, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability via summary scores and statistics of study-designed treatment engagement and acceptability assessment instruments
Feasibility via average rate of enrollment of eligible participants
Feasibility via computed fraction of participants who have completed all assessment in this study
Secondary outcome measures
Change in alcohol consumption via average amount of alcohol consumed per drinking day
Change in alcohol consumption via number of drinking days
Feasibility via computed fraction of participants that successfully completed at least 1 of each activity independently as per record in treatment booklet
+1 more

UBA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: UBA ArmExperimental Treatment1 Intervention
All subjects in this arm will receive ultrabrief behavioral activation therapy via a single, 90-minute session.
Group II: Control ArmActive Control1 Intervention
All subjects in this arm will complete all study assessment instruments collected in the interventional arm but will not receive an intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrabrief Behavioral Activation
2022
N/A
~40

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,515 Previous Clinical Trials
4,194,268 Total Patients Enrolled
Stacy Daughters, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the primary goals of this investigation?

"This medical trial will measure Acceptability using a variety of assessment instruments, Feasibility through participant self-management and therapeutic feedback, and Change in alcohol consumption via number of drinking days. The primary outcome is to be observed over a 3 month period from Baseline up to Post treatment (Follow up 3)."

Answered by AI

Is there a limit to the number of participants being admitted into this trial?

"Affirmative, the clinicaltrial.gov page reveals that this medical research is currently recruiting patients. This study was first advertised on March 8th 2022 and most recently modified on March 18th 2022. The trial needs to recruit 40 individuals from a single centre."

Answered by AI

Are individuals currently allowed to enroll in this investigation?

"Affirmative. The clinicaltrials.gov website confirms that this research is appealing for participants, having first been posted on March 8th 2022 and updated most recently on the 18th of March 2022. 40 patients are required to be enrolled from single medical facility."

Answered by AI
Recent research and studies
~13 spots leftby May 2025